Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 22 studies | 32% ± 10% | |
macrophage | 15 studies | 29% ± 15% | |
monocyte | 12 studies | 30% ± 16% | |
conventional dendritic cell | 11 studies | 26% ± 11% | |
dendritic cell | 10 studies | 30% ± 15% | |
non-classical monocyte | 10 studies | 24% ± 9% | |
myeloid cell | 7 studies | 25% ± 6% | |
mononuclear phagocyte | 3 studies | 28% ± 11% | |
neutrophil | 3 studies | 47% ± 4% | |
intermediate monocyte | 3 studies | 41% ± 13% | |
microglial cell | 3 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of NLRP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 95% | 235.20 | 434 / 459 | 87% | 3.12 | 974 / 1118 |
brain | 84% | 236.21 | 2232 / 2642 | 97% | 6.65 | 684 / 705 |
lung | 99% | 974.92 | 574 / 578 | 79% | 3.04 | 912 / 1155 |
intestine | 91% | 198.82 | 883 / 966 | 61% | 1.71 | 324 / 527 |
thymus | 68% | 102.98 | 446 / 653 | 80% | 2.68 | 483 / 605 |
prostate | 75% | 116.87 | 184 / 245 | 63% | 1.53 | 316 / 502 |
bladder | 76% | 118.10 | 16 / 21 | 58% | 1.95 | 291 / 504 |
kidney | 48% | 85.65 | 43 / 89 | 85% | 3.91 | 766 / 901 |
adrenal gland | 85% | 141.61 | 219 / 258 | 47% | 1.26 | 109 / 230 |
uterus | 69% | 112.65 | 118 / 170 | 61% | 1.50 | 279 / 459 |
stomach | 60% | 121.80 | 215 / 359 | 67% | 1.85 | 191 / 286 |
ovary | 44% | 71.73 | 80 / 180 | 62% | 1.60 | 266 / 430 |
skin | 32% | 48.76 | 581 / 1809 | 74% | 2.68 | 350 / 472 |
pancreas | 23% | 31.12 | 75 / 328 | 83% | 3.38 | 147 / 178 |
esophagus | 57% | 83.41 | 830 / 1445 | 48% | 1.26 | 87 / 183 |
spleen | 100% | 874.52 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 591.80 | 1183 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 265.17 | 1152 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 4335.18 | 764 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 2.10 | 34 / 45 |
lymph node | 0% | 0 | 0 / 0 | 72% | 2.45 | 21 / 29 |
liver | 24% | 38.95 | 55 / 226 | 29% | 0.65 | 118 / 406 |
heart | 52% | 101.45 | 444 / 861 | 0% | 0 | 0 / 0 |
muscle | 34% | 39.84 | 271 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.16 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0002221 | Biological process | pattern recognition receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0044546 | Biological process | NLRP3 inflammasome complex assembly |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0002674 | Biological process | negative regulation of acute inflammatory response |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_2000553 | Biological process | positive regulation of T-helper 2 cell cytokine production |
GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0098586 | Biological process | cellular response to virus |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0051604 | Biological process | protein maturation |
GO_0007231 | Biological process | osmosensory signaling pathway |
GO_0009595 | Biological process | detection of biotic stimulus |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0006915 | Biological process | apoptotic process |
GO_0045630 | Biological process | positive regulation of T-helper 2 cell differentiation |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006952 | Biological process | defense response |
GO_0002830 | Biological process | positive regulation of type 2 immune response |
GO_0072559 | Cellular component | NLRP3 inflammasome complex |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0000139 | Cellular component | Golgi membrane |
GO_0031021 | Cellular component | interphase microtubule organizing center |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0043531 | Molecular function | ADP binding |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0140608 | Molecular function | cysteine-type endopeptidase activator activity |
GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
GO_0005515 | Molecular function | protein binding |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
GO_0140299 | Molecular function | small molecule sensor activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | NLRP3 |
Protein name | NLRP3 Cryopyrin, NACHT, LRR and PYD domains-containing protein 3 NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-) (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1) NACHT, LRR and PYD domains-containing protein 3 NLR family pyrin domain containing 3 |
Synonyms | CIAS1 NALP3 PYPAF1 C1orf7 hCG_1982559 |
Description | FUNCTION: Sensor component of the NLRP3 inflammasome, which mediates inflammasome activation in response to defects in membrane integrity, leading to secretion of inflammatory cytokines IL1B and IL18 and pyroptosis . In response to pathogens and other damage-associated signals that affect the integrity of membranes, initiates the formation of the inflammasome polymeric complex composed of NLRP3, CASP1 and PYCARD/ASC . Recruitment of pro-caspase-1 (proCASP1) to the NLRP3 inflammasome promotes caspase-1 (CASP1) activation, which subsequently cleaves and activates inflammatory cytokines IL1B and IL18 and gasdermin-D (GSDMD), promoting cytokine secretion and pyroptosis . Activation of NLRP3 inflammasome is also required for HMGB1 secretion; stimulating inflammatory responses . Under resting conditions, ADP-bound NLRP3 is autoinhibited . NLRP3 activation stimuli include extracellular ATP, nigericin, reactive oxygen species, crystals of monosodium urate or cholesterol, amyloid-beta fibers, environmental or industrial particles and nanoparticles, such as asbestos, silica, aluminum salts, cytosolic dsRNA, etc . Almost all stimuli trigger intracellular K(+) efflux (By similarity). These stimuli lead to membrane perturbation and activation of NLRP3 (By similarity). Upon activation, NLRP3 is transported to microtubule organizing center (MTOC), where it is unlocked by NEK7, leading to its relocalization to dispersed trans-Golgi network (dTGN) vesicle membranes and formation of an active inflammasome complex . Associates with dTGN vesicle membranes by binding to phosphatidylinositol 4-phosphate (PtdIns4P) . Shows ATPase activity . .; FUNCTION: Independently of inflammasome activation, regulates the differentiation of T helper 2 (Th2) cells and has a role in Th2 cell-dependent asthma and tumor growth (By similarity). During Th2 differentiation, required for optimal IRF4 binding to IL4 promoter and for IRF4-dependent IL4 transcription (By similarity). Binds to the consensus DNA sequence 5'-GRRGGNRGAG-3' (By similarity). May also participate in the transcription of IL5, IL13, GATA3, CCR3, CCR4 and MAF (By similarity). . |
Accessions | ENST00000474792.2 ENST00000642259.1 A0A7I2UNQ2 ENST00000391828.8 A0A7I2YME5 Q96P20 A0A7I2R3P8 A0A7I2PJH0 A0A7I2PRX0 A0A4Y5USH5 ENST00000348069.7 ENST00000366496.7 ENST00000391827.3 ENST00000643234.2 A0A7I2PMC6 ENST00000336119.8 ENST00000697350.1 A0A345Z977 A0A2R8YEG7 |